CN103800827A - Traditional Chinese medicine for treating liver cancer - Google Patents
Traditional Chinese medicine for treating liver cancer Download PDFInfo
- Publication number
- CN103800827A CN103800827A CN201410046561.5A CN201410046561A CN103800827A CN 103800827 A CN103800827 A CN 103800827A CN 201410046561 A CN201410046561 A CN 201410046561A CN 103800827 A CN103800827 A CN 103800827A
- Authority
- CN
- China
- Prior art keywords
- grams
- radix
- gram
- herba
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention discloses a traditional Chinese medicine for treating liver cancer, which is prepared from 4-16g of oldenlandia, 3-12g of radix bupleuri, 10-16g of oriental wormwood, 16-30g of Chinese date, 10-20g of herba abri, 4-14g of radix curcumae, 6-13g of white peony root, 10-20g of licorice, 15-30g of radix isatidis, 10-18g of Herba Patriniae, 6-13g of honeysuckle flower, 10-20g of Bighead Atractylodes Rhizome, 4-19g of Barbat Skullcap, 3-9g of kudzu root and 4-10g of radix salviae miltiorrhizae. The traditional Chinese medicine has the advantages of simple preparation process, favorable absorption effect, obvious curative effect, no side effect and high safety, and is beneficial to relieving symptoms for patients in time.
Description
Technical field
The present invention relates to a kind of Chinese medicine of Hepatoma therapy.
Background technology
Day by day serious along with environmental pollution, people are subject to the impact of the factor such as chemistry, physics, and the sickness rate of cancer is more and more higher.Wherein hepatocarcinoma is one of common malignant tumor of China, and mortality rate is high, is only second to gastric cancer, esophageal carcinoma in mortality of malignant tumors cis-position.Medical science adopts operation, radiation and chemotherapy to the Therapeutic Method of cancer now, the equal defectiveness of these methods, wherein only have early stage patient just can carry out operative treatment, operative treatment is the means of topical therapeutic, like water off a duck's back to transferring to tumor cell in blood or its hetero-organization, radiotherapy, chemotherapy can effectively be killed and wounded cancerous cell, but can kill and wound normal cell again and cause patient's immunologic function suppressed simultaneously, there is more complication, bring very big damage to patient body.
Summary of the invention
The object of this invention is to provide a kind of Chinese medicine of Hepatoma therapy.
In order to realize foregoing invention object, feature of the present invention is to be made by weight ratio by following crude drug: Herba Hedyotidis Diffusae 4-16 gram, Radix Bupleuri 3-12 gram, Herba Artemisiae Scopariae 10-16 gram, Fructus Jujubae 16-30 gram, Herba Abri 10-20 gram, Radix Curcumae 4-14 gram, Radix Paeoniae Alba 6-13 gram, Radix Glycyrrhizae 10-20 gram, Radix Isatidis 15-30 gram, Herba Patriniae 10-18 gram, Flos Lonicerae 6-13 gram, Rhizoma Atractylodis Macrocephalae 10-20 gram, Herba Scutellariae Barbatae 4-19 gram, Radix Puerariae 3-9 gram, Radix Salviae Miltiorrhizae 4-10 gram.
The Chinese medicine optimum ratio of Hepatoma therapy is: 9 grams of Herba Hedyotidis Diffusaes, 8 grams of Radix Bupleuri, 12 grams of Herba Artemisiae Scopariaes, 20 grams, Fructus Jujubae, 14 grams of Herba Abris, 9 grams of Radix Curcumaes, 10 grams of the Radix Paeoniae Albas, 15 grams, Radix Glycyrrhizae, 20 grams of Radix Isatidis, 14 grams of Herba Patriniae, 11 grams of Flos Loniceraes, 16 grams of the Rhizoma Atractylodis Macrocephalaes, 9 grams of Herba Scutellariae Barbataes, 7 grams of Radix Puerariaes, 8 grams of Radix Salviae Miltiorrhizaes.
In prescription, the drug effect of each taste Chinese medicine is as described below.
Herba Hedyotidis Diffusae heat-clearing and toxic substances removing, dampness removing.
Radix Bupleuri clearind deficient heat, for cold, fever, stagnation of QI due to depression of the liver.
Herba Artemisiae Scopariae clearing away damp-heat, jaundice eliminating subcutaneous ulcer.
Fructus Jujubae spleen reinforcing stomach function regulating, supplementing QI for promoting the production of body fluid.
Herba Abri clearing away heat-damp and promoting diuresis, eliminating stasis to stop pain.
Radix Curcumae regulating qi to disperse stagnation, clear away heart-fire and separate tired, promoting the function of the gallbladder to alleviate jaundice.
Radix Paeoniae Alba analgesia, spasmolytic, hepatoprotective, blood pressure lowering.
Radix Glycyrrhizae invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing.
Radix Isatidis heat-clearing and toxic substances removing, removing heat from blood detumescence, sore-throat relieving.
Herba Patriniae heat-clearing and toxic substances removing, removing heat from blood, invigorates blood circulation, evacuation of pus.
Flos Lonicerae heat-clearing and toxic substances removing.
Rhizoma Atractylodis Macrocephalae invigorating the spleen and benefiting QI, dampness diuretic, hidroschesis.
Herba Scutellariae Barbatae heat-clearing and toxic substances removing, blood circulation promoting and blood stasis dispelling, reducing swelling and alleviating pain, anticancer.
Radix Puerariae improves hepatocellular regeneration capacity, recovers liver function.
Radix Salviae Miltiorrhizae promoting blood flow to regulate menstruation, stasis-dispelling and pain-killing, removing heat from blood eliminating carbuncle, the relieving restlessness that clears away heart-fire, nourishing blood to tranquillize the mind.
Using method of the present invention is: crude drug is soaked in water 30 minutes, decocts 60 minutes, decoct 2 times for every dose, gained medicinal liquid is mixed.1 dose of every day, point 2 decoction being taken warmly.It within 30th, is a course for the treatment of.
Therapeutic effect: in 300 routine patients, clinical cure 276 examples, account for 92%; Effective 18 examples, account for 6%; Effective 2 examples, account for 0.67%; Invalid 4 examples, account for 1.3%.
As can be seen here, the present invention has the following advantages: preparation is simple, and good absorbing effect is evident in efficacy, has no side effect, safe, is conducive to patient and alleviates in time condition of illness.
The specific embodiment
9 grams of embodiment 1 Herba Hedyotidis Diffusaes, 8 grams of Radix Bupleuri, 12 grams of Herba Artemisiae Scopariaes, 20 grams, Fructus Jujubae, 14 grams of Herba Abris, 9 grams of Radix Curcumaes, 10 grams of the Radix Paeoniae Albas, 15 grams, Radix Glycyrrhizae, 20 grams of Radix Isatidis, 14 grams of Herba Patriniae, 11 grams of Flos Loniceraes, 16 grams of the Rhizoma Atractylodis Macrocephalaes, 9 grams of Herba Scutellariae Barbataes, 7 grams of Radix Puerariaes, 8 grams of Radix Salviae Miltiorrhizaes.
4 grams of embodiment 2 Herba Hedyotidis Diffusaes, 3 grams of Radix Bupleuri, 10 grams of Herba Artemisiae Scopariaes, 16 grams, Fructus Jujubae, 10 grams of Herba Abris, 4 grams of Radix Curcumaes, 6 grams of the Radix Paeoniae Albas, 10 grams, Radix Glycyrrhizae, 15 grams of Radix Isatidis, 10 grams of Herba Patriniae, 6 grams of Flos Loniceraes, 10 grams of the Rhizoma Atractylodis Macrocephalaes, 4 grams of Herba Scutellariae Barbataes, 3 grams of Radix Puerariaes, 4 grams of Radix Salviae Miltiorrhizaes.
16 grams of embodiment 3 Herba Hedyotidis Diffusaes, 12 grams of Radix Bupleuri, 16 grams of Herba Artemisiae Scopariaes, 30 grams, Fructus Jujubae, 20 grams of Herba Abris, 14 grams of Radix Curcumaes, 13 grams of the Radix Paeoniae Albas, 20 grams, Radix Glycyrrhizae, 30 grams of Radix Isatidis, 18 grams of Herba Patriniae, 13 grams of Flos Loniceraes, 20 grams of the Rhizoma Atractylodis Macrocephalaes, 19 grams of Herba Scutellariae Barbataes, 9 grams of Radix Puerariaes, 10 grams of Radix Salviae Miltiorrhizaes.
12 grams of embodiment 4 Herba Hedyotidis Diffusaes, 7 grams of Radix Bupleuri, 11 grams of Herba Artemisiae Scopariaes, 20 grams, Fructus Jujubae, 15 grams of Herba Abris, 12 grams of Radix Curcumaes, 9 grams of the Radix Paeoniae Albas, 14 grams, Radix Glycyrrhizae, 20 grams of Radix Isatidis, 16 grams of Herba Patriniae, 9 grams of Flos Loniceraes, 15 grams of the Rhizoma Atractylodis Macrocephalaes, 16 grams of Herba Scutellariae Barbataes, 6 grams of Radix Puerariaes, 7 grams of Radix Salviae Miltiorrhizaes.
Claims (2)
1. a Chinese medicine for Hepatoma therapy, is characterized in that being made by weight ratio by following crude drug: Herba Hedyotidis Diffusae 4-16 gram, Radix Bupleuri 3-12 gram, Herba Artemisiae Scopariae 10-16 gram, Fructus Jujubae 16-30 gram, Herba Abri 10-20 gram, Radix Curcumae 4-14 gram, Radix Paeoniae Alba 6-13 gram, Radix Glycyrrhizae 10-20 gram, Radix Isatidis 15-30 gram, Herba Patriniae 10-18 gram, Flos Lonicerae 6-13 gram, Rhizoma Atractylodis Macrocephalae 10-20 gram, Herba Scutellariae Barbatae 4-19 gram, Radix Puerariae 3-9 gram, Radix Salviae Miltiorrhizae 4-10 gram.
2. the Chinese medicine of Hepatoma therapy according to claim 1, is characterized in that being made by weight ratio by following crude drug: 9 grams of Herba Hedyotidis Diffusaes, 8 grams of Radix Bupleuri, 12 grams of Herba Artemisiae Scopariaes, 20 grams, Fructus Jujubae, 14 grams of Herba Abris, 9 grams of Radix Curcumaes, 10 grams of the Radix Paeoniae Albas, 15 grams, Radix Glycyrrhizae, 20 grams of Radix Isatidis, 14 grams of Herba Patriniae, 11 grams of Flos Loniceraes, 16 grams of the Rhizoma Atractylodis Macrocephalaes, 9 grams of Herba Scutellariae Barbataes, 7 grams of Radix Puerariaes, 8 grams of Radix Salviae Miltiorrhizaes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410046561.5A CN103800827A (en) | 2014-01-24 | 2014-01-24 | Traditional Chinese medicine for treating liver cancer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410046561.5A CN103800827A (en) | 2014-01-24 | 2014-01-24 | Traditional Chinese medicine for treating liver cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103800827A true CN103800827A (en) | 2014-05-21 |
Family
ID=50698522
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410046561.5A Pending CN103800827A (en) | 2014-01-24 | 2014-01-24 | Traditional Chinese medicine for treating liver cancer |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103800827A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104116815A (en) * | 2014-07-29 | 2014-10-29 | 宜都市中医医院 | Stasis and stagnation eliminating decoction for treating primary hepatic carcinoma and preparation method thereof |
| CN104707045A (en) * | 2015-04-03 | 2015-06-17 | 青岛云天生物技术有限公司 | Pharmaceutical composition for treating liver cancer |
| CN105233149A (en) * | 2015-09-26 | 2016-01-13 | 张文俊 | Traditional Chinese medicine patent prescription for treating liver cancers |
| CN106075303A (en) * | 2016-07-19 | 2016-11-09 | 黄九宁 | A kind of Chinese medicine treating the postoperative emboli syndrome of hepatocarcinoma TACE |
| CN107596272A (en) * | 2017-10-13 | 2018-01-19 | 冉仁宇 | A kind of Chinese medicine for treating liver cancer, cancer of the esophagus |
-
2014
- 2014-01-24 CN CN201410046561.5A patent/CN103800827A/en active Pending
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104116815A (en) * | 2014-07-29 | 2014-10-29 | 宜都市中医医院 | Stasis and stagnation eliminating decoction for treating primary hepatic carcinoma and preparation method thereof |
| CN104707045A (en) * | 2015-04-03 | 2015-06-17 | 青岛云天生物技术有限公司 | Pharmaceutical composition for treating liver cancer |
| CN105233149A (en) * | 2015-09-26 | 2016-01-13 | 张文俊 | Traditional Chinese medicine patent prescription for treating liver cancers |
| CN106075303A (en) * | 2016-07-19 | 2016-11-09 | 黄九宁 | A kind of Chinese medicine treating the postoperative emboli syndrome of hepatocarcinoma TACE |
| CN107596272A (en) * | 2017-10-13 | 2018-01-19 | 冉仁宇 | A kind of Chinese medicine for treating liver cancer, cancer of the esophagus |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102671130A (en) | Anti-tumor traditional Chinese medicine | |
| CN101049490A (en) | Herb water of angelica and Chinese mugwort leaves | |
| CN103316174B (en) | Traditional Chinese medicinal composition for treating acute cholecystitis and preparation method thereof | |
| CN103800827A (en) | Traditional Chinese medicine for treating liver cancer | |
| CN104383390A (en) | Chinese traditional medicine preparation for treating lung cancer | |
| CN102357211B (en) | Traditional Chinese medicine composition for curing cancers | |
| CN104027461B (en) | A kind of Chinese medicine composition treating urticaria | |
| CN103656042B (en) | A kind of medicine for the treatment of herpes zoster | |
| CN102441155A (en) | Chinese patent medicine for warming meridians and expelling cold | |
| CN104000893A (en) | Traditional Chinese medicine oral liquid for treating rhinitis | |
| CN103301328B (en) | Trigeminal neuralgia treatment medicine | |
| CN102920951A (en) | Traditional Chinese medicine for treating gastric cancer | |
| CN103505643A (en) | Medicament for treating postpartum urinary retention | |
| CN103239656B (en) | Traditional Chinese medicine for treating psoriasis | |
| CN103006997B (en) | Medicine for treating post-craniotomy headache | |
| CN102526514B (en) | Medicine used for treating allergic purpura | |
| CN103800799A (en) | Traditional Chinese medicine for treating stomach cancer | |
| CN103800601A (en) | Traditional Chinese medicine composition for treating hepatitis | |
| CN102670919A (en) | Chinese medicament for treating chronic pyelonephritis | |
| CN103800456A (en) | Traditional Chinese medicine composition for treating liver cancer | |
| CN102078432A (en) | Medicament for treating skin itch | |
| CN102579718A (en) | Chinese medicament for treating kidney qi deficiency type prostatitis | |
| CN102204991A (en) | Medicament for treating seborrheic dermatitis | |
| CN102038834A (en) | Traditional Chinese medicine preparation for preventing and treating cancers | |
| CN102755534B (en) | Health care herbal medicine for treating prostatitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140521 |